Which has the lower trailing P/E, HUM or NVS?

NVS has the lower trailing P/E: HUM trades at 36.78 and NVS at 21.27. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, HUM or NVS?

Over the past five years, HUM grew revenue faster — HUM at a 12.61% CAGR versus NVS at 1.53%.

Does HUM or NVS pay a bigger dividend?

HUM yields 0.70% and NVS yields 3.38% based on trailing dividends and the latest price.

Is HUM or NVS more profitable?

NVS runs the higher net margin — HUM at 0.88% versus NVS at 22.93%.

How have HUM and NVS total returns compared?

Over the past 10 years, HUM delivered 8.85% and NVS delivered 11.99% annualized total return. Past performance doesn't predict future results.

Humana Inc. (HUM) vs Novartis AG (NVS)

A side-by-side comparison of Humana Inc. and Novartis AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.

HUM

Humana Inc.

$46.63B

$388.36HealthcareDelayed quote: Oct 2, 2026, 4:01 PM EDT

NVS

Novartis AG

$268.00B

$141.00HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — HUM vs NVS

growth of $100 · dividends reinvested · last 10y

HUM +131.4% (+8.8%/yr)NVS +209.2% (+12.0%/yr)NVS compounded faster over this window

HUM NVS

HUM vs NVS: by the numbers

•NVS is the larger company ($268.00B vs $46.63B market cap).
•NVS trades at the lower trailing earnings multiple (21.27 vs 36.78 P/E), one valuation lens rather than an overall verdict.
•NVS converts more revenue to profit (22.93% vs 0.88% net margin).
•HUM grew revenue faster over the past five years (12.61% vs 1.53% CAGR).
•NVS pays the higher dividend yield (3.38% vs 0.70%).

Metrics side by side

Valuation

Metric	HUM	NVS
P/E ratio	36.78	21.27
Forward P/E	42.41	16.02
PEG ratio	N/A	1.38
P/S ratio	0.32	4.82
P/B ratio	2.43	6.45
EV / EBITDA	19.47	13.85
FCF yield	N/A	5.90%

Profitability

Metric	HUM	NVS
Gross margin	13.65%	74.44%
Operating margin	1.39%	30.54%
Net margin	0.88%	22.93%
ROE	6.65%	30.71%
ROIC	4.52%	13.93%

Dividends

Metric	HUM	NVS
Dividend yield	0.70%	3.38%
Payout ratio	25.14%	71.50%

Growth (annualized)

Metric	HUM	NVS
Revenue CAGR (5Y)	12.61%	1.53%
EPS CAGR (5Y)	-17.27%	15.42%
FCF CAGR (5Y)	N/A	8.92%
Total return CAGR (5Y)	0.35%	16.96%

Frequently asked

Which has the lower trailing P/E, HUM or NVS?: NVS has the lower trailing P/E: HUM trades at 36.78 and NVS at 21.27. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, HUM or NVS?: Over the past five years, HUM grew revenue faster — HUM at a 12.61% CAGR versus NVS at 1.53%.
Does HUM or NVS pay a bigger dividend?: HUM yields 0.70% and NVS yields 3.38% based on trailing dividends and the latest price.
Is HUM or NVS more profitable?: NVS runs the higher net margin — HUM at 0.88% versus NVS at 22.93%.
How have HUM and NVS total returns compared?: Over the past 10 years, HUM delivered 8.85% and NVS delivered 11.99% annualized total return. Past performance doesn't predict future results.

Go deeper

Full HUM analysis Full NVS analysis Interactive comparison tool

Dig into the metrics

Humana P/E ratio Novartis AG P/E ratio Humana dividend yield Novartis AG dividend yield Humana ROE Novartis AG ROE Humana operating margin Novartis AG operating margin Humana revenue growth Novartis AG revenue growth Humana free cash flow Novartis AG free cash flow

Humana & Novartis AG appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.